A carregar...
Contribution of capecitabine for therapy of patients with gastroesophageal cancer: an update of recent phase III results
BACKGROUND: Capecitabine, an orally administered fluoropyrimidines, is widely used in the treatment of multiple malignancies. It has been extensively evaluated in patients with gastroesophageal carcinoma. Since recent reviews have discussed phase I/II trials (Cancer 107:221–231, 2006; Drugs 67:601–6...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2503649/ https://ncbi.nlm.nih.gov/pubmed/18728703 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|